WntResearch AB
WNT | SPGR
Overview
Corporate Details
- ISIN(s):
- SE0021149994 (+3 more)
- LEI:
- 25490079GOIBZYTJMF21
- Country:
- Sweden
- Address:
- Jarnakravagen 3, 222 25 Lund
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
WntResearch is active in biotechnology and is developing a therapy to counteract cancer metastases. The company's research is focused on studies of the body's own protein WNT5A, which has been seen in studies to affect the ability of tumor cells to move and spread. The company's drug candidate Foxy-5 is a peptide that mimics the function of WNT5A and is being evaluated in the phase 2 clinical trial NeoFox, in patients with stage II-III colon cancer. The company was founded in 2007 and has its headquarters in Malmö.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for WntResearch AB.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Automate Your Workflow. Get a real-time feed of all WntResearch AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for WntResearch AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-04-08 | Viktor Modigh | Other | Buy | 20,000 | 14,000.00 SEK |
| 2025-04-07 | Viktor Modigh | Other | Buy | 50,000 | 25,500.00 SEK |
| 2025-04-04 | Arne Thor AB | Other | Other | 38,997,631 | 41,536,376.78 SEK |
| 2025-04-04 | Viktor Modigh | Other | Other | 16,675,443 | 17,761,014.34 SEK |
| 2025-04-04 | Viktor Modigh | Other | Other | 2,194,061 | 2,336,894.37 SEK |
| 2025-04-04 | Latitud 58 AB | Other | Other | 1,460,973 | 1,556,082.34 SEK |
| 2025-04-04 | Hans-Peter Oslter | Other | Other | 720,368 | 767,263.96 SEK |
| 2025-04-04 | Hans-Peter Oslter | Other | Other | 716,900 | 763,570.19 SEK |
| 2025-04-04 | Viktor Modigh | Other | Buy | 100,000 | 49,000.00 SEK |
| 2025-04-03 | Luizio AB | Other | Buy | 982,268 | 1,046,213.65 SEK |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
AB Science | France | AB | |
|
Acticor Biotech | France | ALACT | |
|
Active Biotech | Sweden | ACTI | |
|
AcuCort AB | Sweden | ACUC |